1. Methyl-binding DNA capture Sequencing for Patient Tissues
- Author
-
Yao V. Wang, Rohit R. Jadhav, Ya Ting Hsu, Dawn Garcia, Joseph Liu, Victor X. Jin, Zhao Lai, and Tim H M Huang
- Subjects
Genetics ,General Immunology and Microbiology ,Sequence analysis ,General Chemical Engineering ,General Neuroscience ,Computational Biology ,Methylation ,DNA ,Sequence Analysis, DNA ,Biology ,DNA Methylation ,Article ,General Biochemistry, Genetics and Molecular Biology ,Epigenesis, Genetic ,chemistry.chemical_compound ,chemistry ,DNA methylation ,Illumina Methylation Assay ,Humans ,Epigenetics ,Gene ,Illumina dye sequencing - Abstract
Methylation is one of the essential epigenetic modifications to the DNA, which is responsible for the precise regulation of genes required for stable development and differentiation of different tissue types. Dysregulation of this process is often the hallmark of various diseases like cancer. Here, we outline one of the recent sequencing techniques, Methyl-Binding DNA Capture sequencing (MBDCap-seq), used to quantify methylation in various normal and disease tissues for large patient cohorts. We describe a detailed protocol of this affinity enrichment approach along with a bioinformatics pipeline to achieve optimal quantification. This technique has been used to sequence hundreds of patients across various cancer types as a part of the 1,000 methylome project (Cancer Methylome System).
- Published
- 2016
- Full Text
- View/download PDF